NorMIGS - a Study of Micro-invasive Glaucoma Surgery

University of Oslo (UIO)

Status: Enrolling

Conditions: Glaucoma

Treatments: Procedure: Preserflo microshunt; Procedure: Other MIGS; Procedure: Trabeculectomy

Study type: Observational

Funder types: Other

Identifiers

NCT05340647

415116

Details and patient eligibility

About

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
• Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS
• Ability to cooperate fairly well during the examinations
• Willing to participate in the study and capable of providing informed consent

Exclusion criteria

• High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma

Trial design

100 participants in 3 patient groups

Group 1 Preserflo microshunt

Treatment:

Procedure: Preserflo microshunt

Group 2 Trabeculectomy

Treatment:

Procedure: Trabeculectomy

Group 3 Other MIGS

Description:

Other micro-invasive glaucoma surgery (MIGS) than Preserflo microshunt (e.g., Xen gel stent, iStent inject)

Treatment:

Procedure: Other MIGS